United States · FDA National Drug Code directory
Bisoprolol Fumarate and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10135-741_3f7bca13-71ae-c3ed-e063-6294a90ac734
- Product NDC
- 10135-741
- Form
- TABLET
- Composition / generic term
- Bisoprolol Fumarate and Hydrochlorothiazide
- Labeler
- Marlex Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220501
- Source listing expiry
- 20261231
Source-listed ingredients
- BISOPROLOL FUMARATE — 5 mg/1
- HYDROCHLOROTHIAZIDE — 6.25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (10135-741-01) · 10135-741-01
- 500 TABLET in 1 BOTTLE (10135-741-05) · 10135-741-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →